Cumberland Pharmaceuticals Shares Outstanding 2009-2018 | CPIX

Cumberland Pharmaceuticals shares outstanding from 2009 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Cumberland Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2017 16
2016 16
2015 17
2014 18
2013 18
2012 20
2011 21
2010 21
2009 18
2008 17
Cumberland Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 16
Q2 2018 16
Q1 2018 16
Q4 2017 16
Q3 2017 16
Q2 2017 16
Q1 2017 16
Q4 2016 16
Q3 2016 17
Q2 2016 16
Q1 2016 16
Q4 2015 17
Q3 2015 17
Q2 2015 17
Q1 2015 17
Q4 2014 18
Q3 2014 18
Q2 2014 18
Q1 2014 18
Q4 2013 18
Q3 2013 18
Q2 2013 18
Q1 2013 19
Q4 2012 20
Q3 2012 20
Q2 2012 20
Q1 2012 20
Q4 2011 21
Q3 2011 21
Q2 2011 21
Q1 2011 21
Q4 2010 21
Q3 2010 21
Q2 2010 21
Q1 2010 21
Q4 2009 18
Q3 2009 19
Q2 2009 16
Q1 2009 16
Q4 2008 0
Q3 2008 17
Q2 2008 16
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.086B $0.041B
Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in phase III clinical trials, is an intravenous formulation of ibuprofen for the treatment of both pain and fever. Its products also comprise Acetadote, an intravenous formulation of N-acetylcysteine for the treatment of acetaminophen poisoning; and Kristalose, a prescription laxative product, which is a crystalline form of lactulose to enhance patient acceptance and compliance. In addition, the company is developing a treatment for fluid buildup in the lungs of cancer patients and an anti-infective for treating fungal infections in immuno-compromised patients.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $45.191B 30.06
Takeda Pharmaceutical (TAK) Japan $31.497B 11.65
Grifols (GRFS) Spain $13.400B 16.24
Ionis Pharmaceuticals (IONS) United States $8.030B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.648B 10.98
Tilray (TLRY) United States $7.556B 0.00
Nektar Therapeutics (NKTR) United States $7.448B 10.68
Neurocrine Biosciences (NBIX) United States $7.208B 466.82
Sage Therapeutics (SAGE) United States $6.954B 0.00
Catalent (CTLT) United States $6.232B 26.09
United Therapeutics (UTHR) United States $5.138B 8.40
FibroGen (FGEN) United States $4.882B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.037B 12.99
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.022B 21.38
USANA Health Sciences (USNA) United States $2.385B 19.47
Endo (ENDP) Ireland $2.369B 3.63
Heron Therapeutics (HRTX) United States $2.211B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.203B 0.00
Zogenix (ZGNX) United States $1.996B 0.00
Portola Pharmaceuticals (PTLA) United States $1.990B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.953B 24.32
Xencor (XNCR) United States $1.896B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.893B 0.00
Aerie Pharmaceuticals (AERI) United States $1.800B 0.00
PTC Therapeutics (PTCT) United States $1.785B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.705B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.655B 223.61
Theravance Biopharma (TBPH) Cayman Islands $1.496B 0.00
Corcept Therapeutics (CORT) United States $1.307B 19.19
TherapeuticsMD (TXMD) United States $1.299B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.242B 0.00
Esperion Therapeutics (ESPR) United States $1.176B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.985B 0.00
Tricida (TCDA) United States $0.961B 0.00
Radius Health (RDUS) United States $0.860B 0.00
ImmunoGen (IMGN) United States $0.833B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.587B 0.00
Karyopharm Therapeutics (KPTI) United States $0.566B 0.00
ChemoCentryx (CCXI) United States $0.560B 44.36
Siga Technologies (SIGA) United States $0.560B 0.00
Flexion Therapeutics (FLXN) United States $0.547B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.540B 0.00
GlycoMimetics (GLYC) United States $0.511B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.510B 30.09
Collegium Pharmaceutical (COLL) United States $0.498B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.479B 0.00
Forty Seven (FTSV) United States $0.476B 0.00
Odonate Therapeutics (ODT) United States $0.447B 0.00
Aptorum Group (APM) China $0.428B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.392B 0.00
Translate Bio (TBIO) United States $0.386B 0.00
Lannett Co Inc (LCI) United States $0.385B 3.58
Akebia Therapeutics (AKBA) United States $0.374B 0.00
ArQule (ARQL) United States $0.361B 0.00
HARPOON THERAPT (HARP) United States $0.350B 0.00
CASI Pharmaceuticals (CASI) United States $0.345B 0.00
KalVista Pharmaceuticals (KALV) United States $0.345B 0.00
Concert Pharmaceuticals (CNCE) United States $0.342B 0.00
Tyme Technologies (TYME) United States $0.330B 0.00
Dermira (DERM) United States $0.314B 0.00
Minerva Neurosciences (NERV) United States $0.306B 0.00
OptiNose (OPTN) United States $0.297B 0.00
Majesco Entertainment (PTE) United States $0.295B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.289B 10.76
Verrica Pharmaceuticals (VRCA) United States $0.286B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.284B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.275B 0.00
Aclaris Therapeutics (ACRS) United States $0.268B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
Mast Therapeutics (SVRA) United States $0.236B 0.00
Opexa Therapeutics (ACER) United States $0.231B 0.00
IMV INC (IMV) Canada $0.217B 0.00
Dova Pharmaceuticals (DOVA) United States $0.216B 0.00
Aratana Therapeutics (PETX) United States $0.213B 0.00
Affimed (AFMD) Germany $0.212B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.211B 0.00
Calithera Biosciences (CALA) United States $0.210B 0.00
Rafael Holdings (RFL) United States $0.207B 0.00
Xeris Pharmaceuticals (XERS) United States $0.206B 0.00
Aldeyra Therapeutics (ALDX) United States $0.203B 0.00
MEI Pharma (MEIP) United States $0.198B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.197B 0.00
ElectroCore (ECOR) United States $0.196B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.189B 0.00
Recro Pharma (REPH) United States $0.188B 0.00
Molecular Templates (MTEM) United States $0.175B 0.00
Redhill Biopharma (RDHL) Israel $0.173B 0.00
Zafgen (ZFGN) United States $0.173B 0.00
Ardelyx (ARDX) United States $0.163B 0.00
AgeX Therapeutics (AGE) United States $0.162B 0.00
Nature's Sunshine Products (NATR) United States $0.159B 0.00
Aquestive Therapeutics (AQST) United States $0.157B 0.00
Ocular Therapeutix (OCUL) United States $0.154B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.153B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.150B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.148B 0.00
Adherex Technologies (FENC) United States $0.143B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.139B 0.00
Neon Therapeutics (NTGN) United States $0.136B 0.00
Jounce Therapeutics (JNCE) United States $0.133B 0.00
MediWound (MDWD) Israel $0.129B 0.00
Cardiome Pharma (CORV) Canada $0.125B 0.00
ProNAi Therapeutics (SRRA) Canada $0.120B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.119B 0.00
DURECT (DRRX) United States $0.119B 0.00
China SXT Pharmaceuticals (SXTC) China $0.116B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.115B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.101B 0.00
Champions Oncology (CSBR) United States $0.098B 0.00
Natural Alternatives (NAII) United States $0.083B 8.13
Nivalis Therapeutics (ALPN) United States $0.083B 0.00
Iterum Therapeutics (ITRM) Ireland $0.081B 0.00
Infinity Pharmaceuticals (INFI) United States $0.078B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.076B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.075B 0.00
Melinta Therapeutics (MLNT) United States $0.075B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.074B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.074B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.071B 0.00
Neos Therapeutics (NEOS) United States $0.071B 0.00
Immune Design (IMDZ) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.068B 0.00
Forward Pharma (FWP) Denmark $0.063B 0.00
Otonomy (OTIC) United States $0.061B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.061B 0.00
Avenue Therapeutics (ATXI) United States $0.061B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.061B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
KemPharm (KMPH) United States $0.056B 0.00
CTI BioPharma (CTIC) United States $0.054B 0.00
Mannatechorporated (MTEX) United States $0.045B 0.00
Genocea Biosciences (GNCA) United States $0.043B 0.00
BioLineRx (BLRX) Israel $0.042B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.042B 0.00
Achaogen (AKAO) United States $0.041B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.041B 0.00
ContraFect (CFRX) United States $0.037B 0.00
Capnia (SLNO) United States $0.036B 0.00
Lipocine (LPCN) United States $0.036B 0.00
Heat Biologics (HTBX) United States $0.034B 0.00
ProPhase Labs (PRPH) United States $0.034B 0.00
NOVAN INC (NOVN) United States $0.030B 0.00
NanoViricides (NNVC) United States $0.029B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.028B 0.00
PharmAthene (ALT) United States $0.025B 0.00
IsoRay (ISR) United States $0.024B 0.00
ESSA Pharma (EPIX) Canada $0.024B 0.00
Can-Fite Biopharma (CANF) Israel $0.023B 0.00
Biomerica (BMRA) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Onconova Therapeutics (ONTX) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Trillium Therapeutics (TRIL) Canada $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.015B 0.00
VAXART, INC (VXRT) United States $0.014B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.014B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Shineco (TYHT) China $0.011B 1.25
OncoGenex Pharmaceuticals (ACHV) United States $0.011B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
Regulus Therapeutics (RGLS) United States $0.009B 0.00
Intellipharmaceutics (IPCI) Canada $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00